UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
EpiZyme, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
29428V104
(CUSIP Number)
December 31, 2014
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 29428V104
1. | Name of Reporting Persons
MPM BioVentures IV-QP, L.P. | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
1,951,645 | ||||
6. | Shared Voting Power
0 | |||||
7. | Sole Dispositive Power
1,951,645 | |||||
8. | Shared Dispositive Power
0 | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
1,951,645 | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
5.7% | |||||
12. | Type of Reporting Person (See Instructions)
PN |
Page 2 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
MPM BioVentures IV GmbH & Co. Beteiligungs KG | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
Germany | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
75,188 | ||||
6. | Shared Voting Power
0 | |||||
7. | Sole Dispositive Power
75,188 | |||||
8. | Shared Dispositive Power
0 | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
75,188 | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
0.2% | |||||
12. | Type of Reporting Person (See Instructions)
PN |
Page 3 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
MPM BioVentures IV Strategic Fund, L.P. | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
331,491 | ||||
6. | Shared Voting Power
0 | |||||
7. | Sole Dispositive Power
331,491 | |||||
8. | Shared Dispositive Power
0 | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
331,491 | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
1.0% | |||||
12. | Type of Reporting Person (See Instructions)
PN |
Page 4 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
MPM Asset Management Investors BV4 LLC | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
55,495 | ||||
6. | Shared Voting Power
0 | |||||
7. | Sole Dispositive Power
55,495 | |||||
8. | Shared Dispositive Power
0 | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
55,495 | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
0.2% | |||||
12. | Type of Reporting Person (See Instructions)
OO |
Page 5 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
MPM BioVentures IV GP LLC | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
0 | ||||
6. | Shared Voting Power
2,358,324* | |||||
7. | Sole Dispositive Power
0 | |||||
8. | Shared Dispositive Power
2,358,324* | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
2,358,324* | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
6.9% | |||||
12. | Type of Reporting Person (See Instructions)
PN |
* | The shares are held as follows: 1,951,645 by MPM BioVentures IV-QP, L.P. (BV IV QP), 75,188 by MPM BioVentures IV GmbH & Co. Beteiligungs KG (BV KG) and 331,491 by MPM BioVentures IV Strategic Fund, L.P. (BV SF). The Reporting Person is the direct general partner of BV IV QP, BV KG and BV SF. |
Page 6 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
MPM BioVentures IV LLC | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
Delaware | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
0 | ||||
6. | Shared Voting Power
2,413,819* | |||||
7. | Sole Dispositive Power
0 | |||||
8. | Shared Dispositive Power
2,413,819* | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
2,413,819* | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
7.1% | |||||
12. | Type of Reporting Person (See Instructions)
OO |
* | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by MPM Asset Management Investors BV4 LLC (AM BV4). The Reporting Person is the indirect general partner of BV IV QP, BV KG and BV SF and the manager of AM BV4. |
Page 7 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
Luke Evnin | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
0 | ||||
6. | Shared Voting Power
2,413,819* | |||||
7. | Sole Dispositive Power
0 | |||||
8. | Shared Dispositive Power
2,413,819* | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
2,413,819* | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
7.1% | |||||
12. | Type of Reporting Person (See Instructions)
IN |
* | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM BioVentures IV GP LLC (MPM IV GP) and MPM BioVentures IV LLC (MPM IV LLC) are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC. |
Page 8 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
Ansbert Gadicke | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
0 | ||||
6. | Shared Voting Power
2,413,819* | |||||
7. | Sole Dispositive Power
0 | |||||
8. | Shared Dispositive Power
2,413,819* | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
2,413,819* | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
7.1% | |||||
12. | Type of Reporting Person (See Instructions)
IN |
* | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC. |
Page 9 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
Vaughn M. Kailian | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
0 | ||||
6. | Shared Voting Power
2,413,819* | |||||
7. | Sole Dispositive Power
0 | |||||
8. | Shared Dispositive Power
2,413,819* | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
2,413,819* | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
7.1% | |||||
12. | Type of Reporting Person (See Instructions)
IN |
* | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC. |
Page 10 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
James Paul Scopa | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
0 | ||||
6. | Shared Voting Power
2,413,819* | |||||
7. | Sole Dispositive Power
0 | |||||
8. | Shared Dispositive Power
2,413,819* | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
2,413,819* | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
7.1% | |||||
12. | Type of Reporting Person (See Instructions)
IN |
* | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC. |
Page 11 of 18
CUSIP No. 29428V104
1. | Name of Reporting Persons
Todd Foley | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨ (b) x | |||||
3. | SEC USE ONLY
| |||||
4. | Citizenship or Place of Organization
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
5. | Sole Voting Power
0 | ||||
6. | Shared Voting Power
2,413,819* | |||||
7. | Sole Dispositive Power
0 | |||||
8. | Shared Dispositive Power
2,413,819* | |||||
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
2,413,819* | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
¨ | |||||
11. | Percent of Class Represented by Amount in Row (9)
7.1% | |||||
12. | Type of Reporting Person (See Instructions)
IN |
* | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC. |
Page 12 of 18
Item 1.
(a) | Name of Issuer |
EpiZyme, Inc.
(b) | Address of Issuers Principal Executive Offices |
400 Technology Square
Cambridge, Massachusetts 02139
Item 2.
(a) | Name of Person Filing |
MPM BioVentures IV-QP, L.P.
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM BioVentures IV Strategic Fund, L.P.
Luke Evnin
Ansbert Gadicke
Vaughn M. Kailian
James Paul Scopa
Todd Foley
(b) | Address of Principal Business Office or, if none, Residence |
c/o MPM Capital LLC
The John Hancock Tower
200 Clarendon Street, 54th Floor
Boston, MA 02116
(c) | Citizenship |
All entities were organized in Delaware except MPM BioVentures IV GmbH & Co. Beteiligungs KG, which was organized in Germany. The individuals are all United States citizens.
(d) | Title of Class of Securities |
Common Stock
(e) | CUSIP Number |
29428V104
Item 3. | If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable
Page 13 of 18
Item 4. | Ownership |
(a) | Amount Beneficially Owned: |
MPM BioVentures IV-QP, L.P. |
1,951,645 | |||
MPM BioVentures IV GmbH & Co. Beteiligungs KG |
75,188 | |||
MPM BioVentures IV Strategic Fund, L.P. |
331,491 | |||
MPM Asset Management Investors BV4 LLC |
55,495 | |||
MPM BioVentures IV GP LLC |
2,358,324 | (1) | ||
MPM BioVentures IV LLC |
2,413,819 | (2) | ||
Ansbert Gadicke |
2,413,819 | (3) | ||
Luke B. Evnin |
2,413,819 | (3) | ||
Vaughn M. Kailian |
2,413,819 | (3) | ||
James Paul Scopa |
2,413,819 | (3) | ||
Todd Foley |
2,413,819 | (3) |
Percent of Class:
MPM BioVentures IV-QP, L.P. |
5.7% | |||
MPM BioVentures IV GmbH & Co. Beteiligungs KG |
0.2% | |||
MPM BioVentures IV Strategic Fund, L.P. |
1.0% | |||
MPM Asset Management Investors BV4 LLC |
0.2% | |||
MPM BioVentures IV GP LLC |
6.9% | |||
MPM BioVentures IV LLC |
7.1% | |||
Ansbert Gadicke |
7.1% | |||
Luke B. Evnin |
7.1% | |||
Vaughn M. Kailian |
7.1% | |||
James Paul Scopa |
7.1% | |||
Todd Foley |
7.1% |
(b) | Number of shares as to which the person has: |
(i) | Sole power to vote or to direct the vote |
MPM BioVentures IV-QP, L.P. |
1,951,645 | |||
MPM BioVentures IV GmbH & Co. Beteiligungs KG |
75,188 | |||
MPM BioVentures IV Strategic Fund, L.P. |
331,491 | |||
MPM Asset Management Investors BV4 LLC |
55,495 | |||
MPM BioVentures IV GP LLC |
0 | |||
MPM BioVentures IV LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke B. Evnin |
0 | |||
Vaughn M. Kailian |
0 | |||
James Paul Scopa |
0 | |||
Todd Foley |
0 |
Page 14 of 18
(ii) | Shared power to vote or to direct the vote |
MPM BioVentures IV-QP, L.P. |
0 | |||
MPM BioVentures IV GmbH & Co. Beteiligungs KG |
0 | |||
MPM BioVentures IV Strategic Fund, L.P. |
0 | |||
MPM Asset Management Investors BV4 LLC |
0 | |||
MPM BioVentures IV GP LLC |
2,358,324 | (1) | ||
MPM BioVentures IV LLC |
2,413,819 | (2) | ||
Ansbert Gadicke |
2,413,819 | (3) | ||
Luke B. Evnin |
2,413,819 | (3) | ||
Vaughn M. Kailian |
2,413,819 | (3) | ||
James Paul Scopa |
2,413,819 | (3) | ||
Todd Foley |
2,413,819 | (3) |
(iii) | Sole power to dispose or to direct the disposition of |
MPM BioVentures IV-QP, L.P. |
1,951,645 | |||
MPM BioVentures IV GmbH & Co. Beteiligungs KG |
75,188 | |||
MPM BioVentures IV Strategic Fund, L.P. |
331,491 | |||
MPM Asset Management Investors BV4 LLC |
55,495 | |||
MPM BioVentures IV GP LLC |
0 | |||
MPM BioVentures IV LLC |
0 | |||
Ansbert Gadicke |
0 | |||
Luke Evnin |
0 | |||
Vaughn M. Kailian |
0 | |||
James Paul Scopa |
0 | |||
Todd Foley |
0 |
(iv) | Shared power to dispose or to direct the disposition of |
MPM BioVentures IV-QP, L.P. |
0 | |||
MPM BioVentures IV GmbH & Co. Beteiligungs KG |
0 | |||
MPM BioVentures IV Strategic Fund, L.P. |
0 | |||
MPM Asset Management Investors BV4 LLC |
0 | |||
MPM BioVentures IV GP LLC |
2,358,324 | (1) | ||
MPM BioVentures IV LLC |
2,413,819 | (2) | ||
Ansbert Gadicke |
2,413,819 | (3) | ||
Luke B. Evnin |
2,413,819 | (3) | ||
Vaughn M. Kailian |
2,413,819 | (3) | ||
James Paul Scopa |
2,413,819 | (3) | ||
Todd Foley |
2,413,819 | (3) |
(1) | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG and 331,491 by BV SF. The Reporting Person is the direct general partner of BV IV QP, BV KG and BV SF. |
(2) | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. The Reporting Person is the indirect general partner of BV IV QP, BV KG and BV SF and the manager of AM BV4. |
(3) | The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV KG, 331,491 by BV SF and 55,495 by AM BV4. MPM IV GP and MPM IV LLC are the direct and indirect general partners of BV IV QP, BV KG and BV SF and MPM IV LLC is the manager of AM BV4. The Reporting Person is a member of MPM IV LLC. |
Page 15 of 18
Item 5. | Ownership of Five Percent or Less of a Class |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.
Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Not Applicable
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. |
Not Applicable
Item 8. | Identification and Classification of Members of the Group |
Not Applicable
Item 9. | Notice of Dissolution of a Group |
Not Applicable
Item 10. | Certification |
Not Applicable
Page 16 of 18
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 4, 2015
MPM BIOVENTURES IV-QP, L.P. | MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG | |||||||
By: |
MPM BioVentures IV GP LLC, its General Partner |
By: | MPM BioVentures IV GP LLC, in its capacity as the Managing Limited Partner | |||||
By: | MPM BioVentures IV LLC, its Managing Member |
By: | MPM BioVentures IV LLC, its Managing Member | |||||
By: | /s/ Luke Evnin |
By: | /s/ Luke Evnin | |||||
Name: Luke Evnin Title: Member |
Name: Luke Evnin Title: Member | |||||||
MPM ASSET MANAGEMENT INVESTORS BV4 LLC | MPM BIOVENTURES IV STRATEGIC FUND, L.P. | |||||||
By: | MPM BioVentures IV LLC its Manager |
By: | MPM BioVentures IV GP LLC, its General Partner | |||||
By: | /s/ Luke Evnin |
By: | MPM BioVentures IV LLC, | |||||
Name: Luke Evnin Title: Member |
its Managing Member | |||||||
By: | /s/ Luke Evnin | |||||||
Name: Title: |
Luke Evnin Member | |||||||
MPM BIOVENTURES IV GP LLC | MPM BIOVENTURES IV LLC | |||||||
By: | MPM BioVentures IV LLC, | By: | /s/ Luke Evnin | |||||
its Managing Member | Name: Title: |
Luke Evnin Member | ||||||
By: | /s/ Luke Evnin |
|||||||
Name: Title: |
Luke Evnin Member |
|||||||
By: | /s/ Luke Evnin |
By: | /s/ Ansbert Gadicke | |||||
Name: Luke Evnin | Name: Ansbert Gadicke | |||||||
By: | /s/ Vaughn M. Kailian |
By: | /s/ James Paul Scopa | |||||
Name: Vaughn M. Kailian | Name: James Paul Scopa | |||||||
By: | /s/ Todd Foley |
|||||||
Name: Todd Foley |
EXHIBITS
A: | Joint Filing Agreement |
Page 17 of 18